Product Code: GVR-4-68039-993-1
Smart Inhalers Market Growth & Trends:
The global smart inhalers market size is expected to reach USD 53.3 billion by 2030 and is projected to grow at a CAGR of 19.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the smart inhaler market is driven by several key factors, including the rising prevalence of respiratory diseases, increased awareness initiatives, the integration of digital technologies in medical devices, and the development of advanced products by market players. The global rise in chronic respiratory diseases, exacerbated by pollution and low immunity, particularly asthma and COPD, fuels demand for inhalers. According to the American Lung Association, approximately 11.7 million people in the U.S., or 4.6% of adults, were diagnosed with COPD in 2022, which is expected to boost demand for technologically advanced inhalers.
Smart inhalers offer benefits over traditional ones, such as dosage reminders, health tracking, adherence support, and data-driven insights. Market players are actively investing in innovative solutions to meet evolving demands. For example, Aptar Pharma introduced HeroTracker Sense in April 2022, transforming conventional inhalers into smart devices, and partnered with Lupin Limited in January 2020 to launch the ADHERO device, which tracks medication usage via the "MyAdhero" application. These advancements are anticipated to drive global demand for smart inhalers.
In addition, government and private sector initiatives are enhancing awareness about respiratory diseases. The American Lung Association's "Addressing COPD" project, launched in November 2022, aims to improve the care of 12.5 million COPD patients in the U.S. Such efforts, combined with the growing availability of advanced devices, significantly contribute to the smart inhaler market's growth.
Smart Inhalers Market Report Highlights:
- Based on type, the market is segmented into dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). The MDI segment held the largest revenue share of 64.0% in 2023 and is anticipated to witness fastest growth from 2024 to 2030. This is attributable to their increasing popularity as they are easy to use in fixed-dose short bursts sprays
- Based on indication, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), and others. The COPD segment dominated the market with a revenue share of 50.7% in 2023, owing to the high prevalence of COPD globally and increasing awareness about this disease. Moreover, the other segment is anticipated to showcase the fastest growth of CAGR 21.8% over the forecast period
- Based on distribution channel, the market is segmented into hospital, retail, and online pharmacies. The hospital pharmacies segment held the largest revenue share of 44.3% in 2023. Hospital pharmacies offer better flexibility, comfort, and convenience for purchasing smart inhalers for hospitalized patients. In addition, the online pharmacies segment is expected to grow at the fastest CAGR of 22.1% over the forecast period
- Based on end use, the market is segmented into hospitals, home care settings, and others. The hospitals segment dominated the market with a market share of 51.3% in 2023. The growth is attributed to the rapid advancements in healthcare infrastructure and expanding public-private partnerships. The home care settings segment is anticipated to showcase fastest growth at a CAGR 20.3% from 2024 to 2030
- In 2023, North America held the largest revenue share of 45.1%, due to its developed healthcare infrastructure and adoption of advanced medical devices. However, Asia Pacific is projected to experience the fastest growth at a CAGR of 21.2%, driven by increasing adoption of digital medical devices and rising awareness of smart inhaler benefits in the region
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.5. Details of primary research
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.1.1. Approach 1: Commodity flow approach
- 1.7.2. Volume price analysis (Model 2)
- 1.7.2.1. Approach 2: Volume price analysis
- 1.8. Research Scope and Assumptions
- 1.8.1. List of Secondary Sources
- 1.8.2. List of Primary Sources
- 1.8.3. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type Outlook
- 2.2.2. Indication Outlook
- 2.2.3. Distribution Channel Outlook
- 2.2.4. End Use Outlook
- 2.2.5. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Smart Inhalers Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Industry Analysis
- 3.2.1. User Perspective Analysis
- 3.2.2. Key End Users
- 3.3. Technology Outlook
- 3.4. Regulatory Framework
- 3.5. Market Dynamics
- 3.5.1. Market Drivers Analysis
- 3.5.1.1. Rising prevalence of respiratory diseases
- 3.5.1.2. Development of technologically advanced solutions
- 3.5.1.3. Growing adoption of digital health technologies
- 3.5.2. Market Restraints Analysis
- 3.5.2.1. Higher cost than traditional inhalers
- 3.5.3. Industry Challenges and Opportunity Analysis
- 3.6. Smart Inhalers Market Analysis Tools
- 3.6.1. Porter's Analysis
- 3.6.1.1. Bargaining power of the suppliers
- 3.6.1.2. Bargaining power of the buyers
- 3.6.1.3. Threats of substitution
- 3.6.1.4. Threats from new entrants
- 3.6.1.5. Competitive rivalry
- 3.6.2. PESTEL Analysis
- 3.6.2.1. Political landscape
- 3.6.2.2. Economic and Social landscape
- 3.6.2.3. Technological landscape
- 3.6.2.4. Environmental landscape
- 3.6.2.5. Legal landscape
- 3.7. Major Deals & Strategic Alliances Analysis in the Smart Inhalers Industry
- 3.8. Impact of COVID-19
Chapter 4. Smart Inhalers Market: Type Estimates & Trend Analysis
- 4.1. Definition and Scope
- 4.2. Type Market Share Analysis, 2023 & 2030
- 4.3. Segment Dashboard
- 4.4. Smart Inhalers Market: By Type, 2018 to 2030
- 4.4.1. Dry Powdered Inhalers (DPIs)
- 4.4.1.1. Dry Powdered Inhalers (DPIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.2. Metered Dose Inhalers (MDIs)
- 4.4.2.1. Metered Dose Inhalers (MDIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Smart Inhalers Market: Indication Estimates & Trend Analysis
- 5.1. Definition and Scope
- 5.2. Indication Market Share Analysis, 2023 & 2030
- 5.3. Segment Dashboard
- 5.4. Smart Inhalers Market: By Indication, 2018 to 2030
- 5.4.1. Asthma
- 5.4.1.1. Asthma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.4.2. COPD
- 5.4.2.1. COPD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.4.3. Others
- 5.4.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Smart Inhalers Market: Distribution Channel Estimates& Trend Analysis
- 6.1. Definition and Scope
- 6.2. Distribution Channel Market Share Analysis, 2023 & 2030
- 6.3. Segment Dashboard
- 6.4. Smart Inhalers Market: By Distribution Channel, 2018 to 2030
- 6.4.1. Hospital Pharmacies
- 6.4.1.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.2. Retail Pharmacies
- 6.4.2.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.3. Online Pharmacies
- 6.4.3.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Smart Inhalers Market: End Use Estimates& Trend Analysis
- 7.1. Definition and Scope
- 7.2. End Use Market Share Analysis, 2023 & 2030
- 7.3. Segment Dashboard
- 7.4. Smart Inhalers Market: By End Use, 2018 to 2030
- 7.4.1. Hospital
- 7.4.1.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.4.2. Homecare Settings
- 7.4.2.1. Homecare Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.4.3. Others
- 7.4.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 8. Smart Inhalers Market: Regional Estimates & Trend Analysis by Country, Type, Indication, Distribution Channel, End Use
- 8.1. Definition and Scope
- 8.2. Regional Market Share Analysis, 2023 & 2030
- 8.3. Regional Market Dashboard
- 8.4. Regional Market Snapshot
- 8.5. SWOT Analysis
- 8.5.1. North America
- 8.5.2. Europe
- 8.5.3. Asia Pacific
- 8.5.4. Latin America
- 8.5.5. Middle East & Africa
- 8.6. Smart Inhalers Market Share, By Region, 2023 & 2030, USD Billion
- 8.7. North America
- 8.7.1. North America Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.7.2. U.S.
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Regulatory Landscape/Reimbursement Scenario
- 8.7.2.3. Competitive Insights
- 8.7.2.4. U.S. Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.7.3. Canada
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Regulatory Landscape/Reimbursement Scenario
- 8.7.3.3. Competitive Insights
- 8.7.3.4. Canada Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8. Europe
- 8.8.1. Europe Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8.2. UK
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. Regulatory Landscape/Reimbursement Scenario
- 8.8.2.3. Competitive Insights
- 8.8.2.4. U.K. Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8.3. Germany
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Regulatory Landscape/Reimbursement Scenario
- 8.8.3.3. Competitive Insights
- 8.8.3.4. Germany Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8.4. France
- 8.8.4.1. Key Country Dynamics
- 8.8.4.2. Regulatory Landscape/Reimbursement Scenario
- 8.8.4.3. Competitive Insights
- 8.8.4.4. France Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8.5. Italy
- 8.8.5.1. Key Country Dynamics
- 8.8.5.2. Regulatory Landscape/Reimbursement Scenario
- 8.8.5.3. Competitive Insights
- 8.8.5.4. Italy Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8.6. Spain
- 8.8.6.1. Key Country Dynamics
- 8.8.6.2. Regulatory Landscape/Reimbursement Scenario
- 8.8.6.3. Competitive Insights
- 8.8.6.4. Spain Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8.7. Russia
- 8.8.7.1. Key Country Dynamics
- 8.8.7.2. Regulatory Landscape/Reimbursement Scenario
- 8.8.7.3. Competitive Insights
- 8.8.7.4. Sweden Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.9. Asia Pacific
- 8.9.1. Asia Pacific Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.9.2. China
- 8.9.2.1. Key Country Dynamics
- 8.9.2.2. Regulatory Landscape/Reimbursement Scenario
- 8.9.2.3. Competitive Insights
- 8.9.2.4. China Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.9.3. Japan
- 8.9.3.1. Key Country Dynamics
- 8.9.3.2. Regulatory Landscape/Reimbursement Scenario
- 8.9.3.3. Competitive Insights
- 8.9.3.4. Japan Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.9.4. India
- 8.9.4.1. Key Country Dynamics
- 8.9.4.2. Regulatory Landscape/Reimbursement Scenario
- 8.9.4.3. Competitive Insights
- 8.9.4.4. India Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.9.5. South Korea
- 8.9.5.1. Key Country Dynamics
- 8.9.5.2. Regulatory Landscape/Reimbursement Scenario
- 8.9.5.3. Competitive Insights
- 8.9.5.4. South Korea Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.9.6. Australia
- 8.9.6.1. Key Country Dynamics
- 8.9.6.2. Regulatory Landscape/Reimbursement Scenario
- 8.9.6.3. Competitive Insights
- 8.9.6.4. Australia Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.9.7. SIngapore
- 8.9.7.1. Key Country Dynamics
- 8.9.7.2. Regulatory Landscape/Reimbursement Scenario
- 8.9.7.3. Competitive Insights
- 8.9.7.4. Thailand Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.10. Latin America
- 8.10.1. Latin America Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.10.2. Brazil
- 8.10.2.1. Key Country Dynamics
- 8.10.2.2. Regulatory Landscape/Reimbursement Scenario
- 8.10.2.3. Competitive Insights
- 8.10.2.4. Brazil Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.10.3. Mexico
- 8.10.3.1. Key Country Dynamics
- 8.10.3.2. Regulatory Landscape/Reimbursement Scenario
- 8.10.3.3. Competitive Insights
- 8.10.3.4. Mexico Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.10.4. Argentina
- 8.10.4.1. Key Country Dynamics
- 8.10.4.2. Regulatory Landscape/Reimbursement Scenario
- 8.10.4.3. Competitive Insights
- 8.10.4.4. Argentina Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.11. Middle East and Africa
- 8.11.1. Middle East and Africa Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.11.2. South Africa
- 8.11.2.1. Key Country Dynamics
- 8.11.2.2. Regulatory Landscape/Reimbursement Scenario
- 8.11.2.3. Competitive Insights
- 8.11.2.4. South Africa Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.11.3. Saudi Arabia
- 8.11.3.1. Key Country Dynamics
- 8.11.3.2. Regulatory Landscape/Reimbursement Scenario
- 8.11.3.3. Competitive Insights
- 8.11.3.4. Saudi Arabia Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.11.4. UAE
- 8.11.4.1. Key Country Dynamics
- 8.11.4.2. Regulatory Landscape/Reimbursement Scenario
- 8.11.4.3. Competitive Insights
- 8.11.4.4. UAE Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis by Key Market Participants
- 9.2. Company Categorization
- 9.3. Company Market Share Analysis
- 9.4. Company Heat Map Analysis
- 9.5. Strategy Mapping
- 9.5.1. Expansion
- 9.5.2. Mergers & Acquisition
- 9.5.3. Partnerships & Collaborations
- 9.5.4. New Product Launches
- 9.5.5. Research And Development
- 9.6. Company Profiles
- 9.6.1. Presspart Verwaltungs GmbH.
- 9.6.1.1. Participant's Overview
- 9.6.1.2. Financial Performance
- 9.6.1.3. Product Benchmarking
- 9.6.1.4. Recent Developments
- 9.6.2. Personal Air Quality Systems Pvt Ltd
- 9.6.2.1. Participant's Overview
- 9.6.2.2. Financial Performance
- 9.6.2.3. Product Benchmarking
- 9.6.2.4. Recent Developments
- 9.6.3. COHERO Health Inc. (AptarGroup, Inc.)
- 9.6.3.1. Participant's Overview
- 9.6.3.2. Financial Performance
- 9.6.3.3. Product Benchmarking
- 9.6.3.4. Recent Developments
- 9.6.4. Cognita Labs
- 9.6.4.1. Participant's Overview
- 9.6.4.2. Financial Performance
- 9.6.4.3. Product Benchmarking
- 9.6.4.4. Recent Developments
- 9.6.5. adherium
- 9.6.5.1. Participant's Overview
- 9.6.5.2. Financial Performance
- 9.6.5.3. Product Benchmarking
- 9.6.5.4. Recent Developments
- 9.6.6. Amiko Digital Health Limited.
- 9.6.6.1. Participant's Overview
- 9.6.6.2. Financial Performance
- 9.6.6.3. Product Benchmarking
- 9.6.6.4. Recent Developments
- 9.6.7. Teva Pharmaceuticals Industries Ltd.
- 9.6.7.1. Participant's Overview
- 9.6.7.2. Financial Performance
- 9.6.7.3. Product Benchmarking
- 9.6.7.4. Recent Developments
- 9.6.8. Propeller Health (ResMed)
- 9.6.8.1. Participant's Overview
- 9.6.8.2. Financial Performance
- 9.6.8.3. Product Benchmarking
- 9.6.8.4. Recent Developments
- 9.6.9. Novartis AG
- 9.6.9.1. Participant's Overview
- 9.6.9.2. Financial Performance
- 9.6.9.3. Product Benchmarking
- 9.6.9.4. Recent Developments
- 9.6.10. Pneuma Respiratory Inc.
- 9.6.10.1. Participant's Overview
- 9.6.10.2. Financial Performance
- 9.6.10.3. Product Benchmarking
- 9.6.10.4. Recent Developments
- 9.6.11. 3M
- 9.6.11.1. Participant's Overview
- 9.6.11.2. Financial Performance
- 9.6.11.3. Product Benchmarking
- 9.6.11.4. Recent Developments
- 9.6.12. AireHealth, Inc.
- 9.6.12.1. Participant's Overview
- 9.6.12.2. Financial Performance
- 9.6.12.3. Product Benchmarking
- 9.6.12.4. Recent Developments
- 9.6.13. FindAir Sp. z o.o
- 9.6.13.1. Participant's Overview
- 9.6.13.2. Financial Performance
- 9.6.13.3. Product Benchmarking
- 9.6.13.4. Recent Developments